1970. Phase 1 Clinical Trial of Intranasal Immunization with M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR): Safety and Immune Response in Adults-Reference-Cited by-同舟云学术

1970. Phase 1 Clinical Trial of Intranasal Immunization with M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR): Safety and Immune Response in Adults

Published:2018-11 Issue:suppl_1 Volume:5 Page:S571-S572
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Eiden Joseph¹,Gordon Gilad²,Fierro Carlos³,Belshe Robert⁴,Greenberg Harry⁵,Hoft Dan⁴,Hatta Yasuko⁶,Imboden Michael⁶,Moser Mike⁶,Herber Renee⁶,Boltz David⁷,Tary-Lehmann Magdalena⁸,Kawaoka Yoshihiro⁹,Neumann Gabriele⁹,Radspinner Paul⁶,Aitchison Roger¹⁰,Bilsel Pamuk⁶

Affiliation:

1. Celyn Consulting, LLC, Lewes, Delaware

2. ORRA Group, LLC, Boulder, Colorado

3. Johnson County Clin-Trials, Lenexa, Kansas

4. Saint Louis University, St. Louis, Missouri

5. Stanford University, Stanford, California

6. FluGen, Inc., Madison, WI

7. IIT Research Institute, Chicago, Illinois

8. Cellular Technology Limited, Shaker Heights, Ohio

9. Influenza Research Institute, University of Wisconsin, Madison, Wisconsin

10. North Rim Consulting, Denver, Colorado

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

http://academic.oup.com/ofid/article-pdf/5/suppl_1/S571/27562538/ofy210.1626.pdf

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. M2-Deficient Single-Replication Influenza Vaccine–Induced Immune Responses Associated With Protection Against Human Challenge With Highly Drifted H3N2 Influenza Strain;The Journal of Infectious Diseases;2021-07-29